Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001774569 | SCV002002032 | uncertain significance | not provided | 2024-12-12 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV004681247 | SCV005181354 | uncertain significance | Inborn genetic diseases | 2024-04-22 | criteria provided, single submitter | clinical testing | The c.4100C>A (p.P1367H) alteration is located in exon 19 (coding exon 18) of the USH2A gene. This alteration results from a C to A substitution at nucleotide position 4100, causing the proline (P) at amino acid position 1367 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |